Literature DB >> 3121614

Retinoic acid-induced differentiation of the mouse teratocarcinoma cell line F9 is accompanied by an increase in the activity of UDP-galactose: beta-D-galactosyl-alpha 1,3-galactosyltransferase.

R D Cummings1, S A Mattox.   

Abstract

We report here that both the mouse teratocarcinoma F9 cells and F9 cells induced to differentiate by treatment with retinoic acid contain cell surface glycoconjugates with terminal alpha-linked galactose residues, as shown by agglutination of cells with antisera to blood type B, but not to type A. In addition, both cell types contain high numbers of binding sites for Griffonia simplicifolia-I, a lectin which binds to terminal alpha-linked galactose residues, although differentiated F9 cells contain approximately 50% more binding sites/cell for this lectin. We have also confirmed that differentiation is accompanied by a decrease in the expression of the fucose-containing stage-specific embryonic antigen (SSEA)-1, as evidenced by the fact that F9 cells, but not differentiated F9 cells, are agglutinated by monoclonal antibody to this antigen. Since these results indicate that surface glycoconjugates contain terminal alpha-linked galactose residues, we assayed cell extracts for the enzyme UDP-Gal:beta-D-Gal-alpha 1,3-galactosyltransferase. We have found that F9 cell extracts contain this activity, and differentiation results in a significant increase in the specific activity of the enzyme, from approximately 2 nmol/mg h in F9 extracts to 7 nmol/mg h in RA/F9 extracts. It has been suggested that the loss of the SSEA-1 antigen upon differentiation of F9 cells is due to decreased activity of the enzyme GDP-Fuc:beta-D-GlcNAc-alpha 1, 3-fucosyltransferase. We therefore determined the activities of this fucosyltransferase and several other glycosyltransferases, which included UDP-GlcNAc:beta-D-Gal-beta 1,3-N-acetylglucosaminyltransferase, UDP-Gal:beta-D-GlcNAc-beta 1,4-galactosyltransferase, and GDP-Fuc:beta-D-GlcNAc-alpha 1,6-fucosyltransferase. We have found that extracts from both cell types contain these enzyme activities; differentiation, however, does not result in substantial changes in any of these activities.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3121614

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Toxin A of Clostridium difficile is a potent cytotoxin.

Authors:  K D Tucker; P E Carrig; T D Wilkins
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

Review 2.  Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential.

Authors:  M Pierce; P Buckhaults; L Chen; N Fregien
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

3.  Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces.

Authors:  R M Hamadeh; G A Jarvis; U Galili; R E Mandrell; P Zhou; J M Griffiss
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

4.  Secretion of alpha1,3-galactosyltransferase by cultured cells and presence of enzyme in animal sera.

Authors:  S K Cho; J C Yeh; R D Cummings
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

5.  Enhancement of glycosylation of cellular glycoconjugates in the squamous carcinoma cell line MDA886Ln by beta-all-trans retinoic acid.

Authors:  P G Sacks; B Amos; R Lotan
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

6.  Regulation of UDP-N-acetylglucosamine:dolichyl-phosphate N-acetylglucosamine-1-phosphate transferase by retinoic acid in P19 cells.

Authors:  J D Meissner; A Naumann; W H Mueller; R J Scheibe
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

7.  Isolation of a cDNA encoding a murine UDPgalactose:beta-D-galactosyl- 1,4-N-acetyl-D-glucosaminide alpha-1,3-galactosyltransferase: expression cloning by gene transfer.

Authors:  R D Larsen; V P Rajan; M M Ruff; J Kukowska-Latallo; R D Cummings; J B Lowe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 8.  Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.

Authors:  U Galili
Journal:  Springer Semin Immunopathol       Date:  1993

9.  Study of O-sialylation of glycoproteins in C6 glioma cells treated with retinoic acid.

Authors:  P Reboul; P George; D Miquel; P Louisot; P Broquet
Journal:  Glycoconj J       Date:  1996-02       Impact factor: 2.916

10.  Retinoic acid modulation of alpha(1-->2) fucosyltransferase activity and sensitivity of tumor cells to LAK-mediated cytotoxicity.

Authors:  N Labarrière; J P Piau; R Zennadi; P Blanchardie; M Denis; P Lustenberger
Journal:  In Vitro Cell Dev Biol       Date:  1993-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.